Announcement on Convening the 2025 Semi-annual Performance Briefing
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Convening the 2025 Semi-annual Performance Briefing
Filed with SSE · · 2 pages · Chinese
Release
Tasly Pharmaceutical Group Co. Ltd. on 6ix
Earlier from Tasly Pharmaceutical
- 2025 Semi-annual Report
- Announcement on Appointment of Senior Management Members
- Announcement on Expiration of Duration and Termination of the Employee Stock Ownership Plan
- Announcement on the Progress of Drug Registration Application
- Announcement on Resolutions of the 10th Meeting of the 9th Board of Directors
Later from Tasly Pharmaceutical
- Announcement on Resolutions of the 13th Meeting of the 9th Board of Directors
- Announcement on Attending 2025 Online Collective Reception Day for Investors of Listed Companies in Tianjin Jurisdiction
- Announcement on Progress in Providing Guarantee for Subsidiary
- Announcement on Using Idle Funds to Purchase Bank Financial Products
- Announcement on Acquisition of Drug Registration Certificate for New Indication of Acute Ischemic Cerebral Stroke of the Wholly-owned Subsidiary's Reocmbinant Human Prourokinase for Injection
Follow Tasly Pharmaceutical into a list and get an email when it puts out news.
Follow Tasly Pharmaceutical